Merck Serono

Shooting for a new standard on osteoarthritis, Merck KGaA outlines promising data for a potential game-changer
Shooting for a new standard on osteoarthritis, Merck KGaA outlines promising data for a potential game-changer
Endpoints
Merck KGaA
osteoarthritis
sprifermin
Merck Serono
Flag link:
Merck KGaA bets on cancer drugs to revitalize German firm
Merck KGaA bets on cancer drugs to revitalize German firm
Yahoo/Reuters
Merck KGaA
cancer
Merck Serono
Rebif
Erbitux
Flag link:
Sofinnova leads a $30.6M round for Asceneuron's Alzheimer's R&D
Sofinnova leads a $30.6M round for Asceneuron's Alzheimer's R&D
Fierce Biotech
Asceneuron
Merck Serono
R&D
Alzheimer's disease
Flag link:
Merck Serono breaks ground on $72M R&D center
Merck Serono breaks ground on $72M R&D center
Fierce Biotech
Merck Serono
R&D
Germany
Flag link:
Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy
Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy
Yahoo
Intrexon
Merck Serono
CAR-T
chimeric antigen receptor T-cell immunotherapies
Flag link:
Ex-Merck Serono team bags €8.7M for PhI Parkinson's program
Ex-Merck Serono team bags €8.7M for PhI Parkinson's program
Fierce Biotech
Merck Serono
Parkinson's Disease
Prexton Therapeutics
Flag link:
Merck Serono Plans to Make China Leader in Oncology Treatment
Merck Serono Plans to Make China Leader in Oncology Treatment
Yibada, China
Merck Serono
China
Flag link:
Merck Serono pledges €150m to biosimilars in 2015
Merck Serono pledges €150m to biosimilars in 2015
Bio-Pharma Reporter
Merck Serono
R&D
biosimilars
Flag link:
The CEO Is In: Pharma Exec Started as Physician
The CEO Is In: Pharma Exec Started as Physician
WSJ Online
physicians
Merck Serono
Pharma CEOs
Flag link:
Merck Serono CEO Eyes Asia for Growth in Cancer, Fertility Drugs
Merck Serono CEO Eyes Asia for Growth in Cancer, Fertility Drugs
Bloomberg
Merck Serono
Fertility
Asia
Merck KGaA
Flag link:
What's Big Pharma's latest hot spot? The Middle East
What's Big Pharma's latest hot spot? The Middle East
Fierce Pharma
Middle East
Merck
Merck Serono
Sanofi
Novo Nordisk
Eli Lilly
Bayer
Flag link:
Merck Serono funds four MS projects
Merck Serono funds four MS projects
Pharma Times, UK
Merck Serono
MS
multiple sclerosis
R&D
Flag link:
China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy
China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy
Seeking Alpha
Valeant Pharmaceuticals
Bausch & Lomb
BeiGene
Merck Serono
Winteam Pharma
Tongjitang Chinese Medicines
Qiagen
Aslan Pharma
Sinovac Biotech
Vigoo Biological
Flag link:
Quintiles, Merck Serono announce clinical development partnership
Quintiles, Merck Serono announce clinical development partnership
Yahoo/Fly on the Wall
Merck Serono
Quintiles
R&D
Flag link:
Merck Serono, Job Cuts And A Bruised Image
Merck Serono, Job Cuts And A Bruised Image
Pharmalot
Merck Serono
layoffs
Flag link:
Merck Serono, Compugen establish Neviah Genomics
Merck Serono, Compugen establish Neviah Genomics
Yahoo/Fly on the Wall
Merck Serono
CompuGen
Neviah Genomics
Flag link:
Pharma Fraud Continues To Fill The US Treasury
Pharma Fraud Continues To Fill The US Treasury
Pharmalot
fraud
Merck Serono
Novo Nordisk
False Claims Act
Flag link:
f-star lands $708M antibody pact with Merck Serono
f-star lands $708M antibody pact with Merck Serono
Fierce Biotech
antibodies
f-star
Merck Serono
Flag link:
Newron, Merck Serono conclude patient recruitment in Phase III MOTION study
Newron, Merck Serono conclude patient recruitment in Phase III MOTION study
Pharmaceutical Business Review
Newron Pharma
Merck Serono
Parkinson's Disease
Flag link:
Merck Serono pays $44M to settle kickback charge
Merck Serono pays $44M to settle kickback charge
Yahoo/AP
Merck Serono
settlements
kickbacks
Rebif
Flag link:

Pages